Linking Proteomic and Transcriptional Data through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling

Cellular signal transduction generally involves cascades of post-translational protein modifications that rapidly catalyze changes in protein-DNA interactions and gene expression. High-throughput measurements are improving our ability to study each of these stages individually, but do not capture the connections between them. Here we present an approach for building a network of physical links among these data that can be used to prioritize targets for pharmacological intervention. Our method recovers the critical missing links between proteomic and transcriptional data by relating changes in chromatin accessibility to changes in expression and then uses these links to connect proteomic and transcriptome data. We applied our approach to integrate epigenomic, phosphoproteomic and transcriptome changes induced by the variant III mutation of the epidermal growth factor receptor (EGFRvIII) in a cell line model of glioblastoma multiforme (GBM). To test the relevance of the network, we used small molecules to target highly connected nodes implicated by the network model that were not detected by the experimental data in isolation and we found that a large fraction of these agents alter cell viability. Among these are two compounds, ICG-001, targeting CREB binding protein (CREBBP), and PKF118–310, targeting β-catenin (CTNNB1), which have not been tested previously for effectiveness against GBM. At the level of transcriptional regulation, we used chromatin immunoprecipitation sequencing (ChIP-Seq) to experimentally determine the genome-wide binding locations of p300, a transcriptional co-regulator highly connected in the network. Analysis of p300 target genes suggested its role in tumorigenesis. We propose that this general method, in which experimental measurements are used as constraints for building regulatory networks from the interactome while taking into account noise and missing data, should be applicable to a wide range of high-throughput datasets.National Science Foundation (U.S.) (DB1-0821391)National Institutes of Health (U.S.) (Grant U54-CA112967)National Institutes of Health (U.S.) (Grant R01-GM089903)National Institutes of Health (U.S.) (P30-ES002109

Computational analysis of transcriptional regulation in metazoans

This HDR thesis presents my work on transcriptional regulation in metazoans (animals). As a computational biologist, my research activities cover both the development of new bioinformatics tools, and contributions to a better understanding of biological questions. The first part focuses on transcription factors, with a study of the evolution of Hox and ParaHox gene families across meta- zoans, for which I developed HoxPred, a bioinformatics tool to automatically classify these genes into their groups of homology. Transcription factors regulate their target genes by binding to short cis-regulatory elements in DNA. The second part of this thesis introduces the prediction of these cis-regulatory elements in genomic sequences, and my contributions to the development of user- friendly computational tools (RSAT software suite and TRAP). The third part covers the detection of these cis-regulatory elements using high-throughput sequencing experiments such as ChIP-seq or ChIP-exo. The bioinformatics developments include reusable pipelines to process these datasets, and novel motif analysis tools adapted to these large datasets (RSAT peak-motifs and ExoProfiler). As all these approaches are generic, I naturally apply them to diverse biological questions, in close collaboration with experimental groups. In particular, this third part presents the studies uncover- ing new DNA sequences that are driving or preventing the binding of the glucocorticoid receptor. Finally, my research perspectives are introduced, especially regarding further developments within the RSAT suite enabling cross-species conservation analyses, and new collaborations with exper- imental teams, notably to tackle the epigenomic remodelling during osteoporosis.Cette thèse d’HDR présente mes travaux concernant la régulation transcriptionelle chez les métazoaires (animaux). En tant que biologiste computationelle, mes activités de recherche portent sur le développement de nouveaux outils bioinformatiques, et contribuent à une meilleure compréhension de questions biologiques. La première partie concerne les facteurs de transcriptions, avec une étude de l’évolution des familles de gènes Hox et ParaHox chez les métazoaires. Pour cela, j’ai développé HoxPred, un outil bioinformatique qui classe automatiquement ces gènes dans leur groupe d’homologie. Les facteurs de transcription régulent leurs gènes cibles en se fixant à l’ADN sur des petites régions cis-régulatrices. La seconde partie de cette thèse introduit la prédiction de ces éléments cis-régulateurs au sein de séquences génomiques, et présente mes contributions au développement d’outils accessibles aux non-spécialistes (la suite RSAT et TRAP). La troisième partie couvre la détection de ces éléments cis-régulateurs grâce aux expériences basées sur le séquençage à haut débit comme le ChIP-seq ou le ChIP-exo. Les développements bioinformatiques incluent des pipelines réutilisables pour analyser ces jeux de données, ainsi que de nouveaux outils d’analyse de motifs adaptés à ces grands jeux de données (RSAT peak-motifs et ExoProfiler). Comme ces approches sont génériques, je les applique naturellement à des questions biologiques diverses, en étroite collaboration avec des groupes expérimentaux. En particulier, cette troisième partie présente les études qui ont permis de mettre en évidence de nouvelles séquences d’ADN qui favorisent ou empêchent la fixation du récepteur aux glucocorticoides. Enfin, mes perspectives de recherche sont présentées, plus particulièrement concernant les nouveaux développements au sein de la suite RSAT pour permettre des analyses basées sur la conservation inter-espèces, mais aussi de nouvelles collaborations avec des équipes expérimentales, notamment pour éudier le remodelage épigénomique au cours de l’ostéoporose